Synergistic potentials of small extracellular vesicles, biomaterials, and 3D bioprinting in periodontal regeneration: a scoping review
Extracellular Vesicles and Circulating Nucleic Acids · 11.12.2025 · 6 (4) · 954-81
DOI: 10.20517/evcna.2025.107 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Extracellular Vesicles and Circulating Nucleic Acids, online erschienen am 11.12.2025. Verfasst von Chenyi Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Dentistry, Centre for Orofacial Regeneration, Rehabilitation and Reconstruction (COR3), Epigenetics nanodiagnostic and therapeutic group, T…. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Periodontitis is a chronic inflammatory disease characterized by the progressive destruction of both soft (gingiva and periodontal ligament) and hard (cementum and alveolar bone) supporting tissues. The complex periodontal microenvironment often limits the effectiveness of current clinical treatments in achieving functional tissue regeneration. Although mesenchymal and immune cell-based therapies hold promise, concerns related to cell viability and immune compatibility limit their clinical translation. As a natural secretome, small extracellular vesicles (sEVs) are cell-secreted nanoparticles that deliver bioactive molecules for cell-to-cell communication to modulate immune response and promote tissue regeneration. To assess the translational readiness of sEVs therapy, this scoping review first outlines the current clinical trials of mesenchymal stem cells (MSCs)-sEVs in periodontitis, followed by a transition to preclinical application of integrating sEVs with biomaterial scaffolds to enhance localized regenerative outcomes. We then analyzed eight preclinical studies utilizing 3D bioprinted MSCs-sEVs/human umbilical vein endothelial cells-sEVs (or immune cell-derived sEVs) constructs in bone and vasculature regeneration models, and one study related to in vitro periodontal regeneration. These constructs exhibited improved outcomes in osteogenesis, angiogenesis, and immunomodulation, supporting their potential for future translational applications in periodontal therapy. Given the early stage of bioprinted sEVs constructs in periodontitis, we outline critical research gaps and potential future directions to overcome current technical and biological challenges. Together, this review demonstrated the translational trajectory of sEV-based strategies for periodontal regeneration. It offers a potential roadmap for utilizing sEV-based periodontal regeneration across clinical, preclinical, and biofabrication applications, highlighting their potential as next-generation, cell-free therapeutics in regenerative periodontics.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Dentistry, Centre for Orofacial Regeneration, Rehabilitation and Reconstruction (COR3), Epigenetics nanodiagnostic and therapeutic group, The University of Queensland, Brisbane 4006, Australia.
Zitieren
APA
Zhang, C., Liu, C., Liaw, A., Ivanovski, S., & Han, P. (2025). Synergistic potentials of small extracellular vesicles, biomaterials, and 3D bioprinting in periodontal regeneration: a scoping review. Extracellular Vesicles and Circulating Nucleic Acids, 6(4), 954-81. https://doi.org/10.20517/evcna.2025.107
Vancouver
Zhang C, Liu C, Liaw A, Ivanovski S, Han P. Synergistic potentials of small extracellular vesicles, biomaterials, and 3D bioprinting in periodontal regeneration: a scoping review. Extracellular Vesicles and Circulating Nucleic Acids. 2025;6(4):954-81. doi:10.20517/evcna.2025.107
BibTeX
@article{Zhang2025,
author = {Zhang, Chenyi and Liu, Chun and Liaw, Andrew and Ivanovski, Sašo and Han, Pingping},
title = {Synergistic potentials of small extracellular vesicles, biomaterials, and 3D bioprinting in periodontal regeneration: a scoping review},
journal = {Extracellular Vesicles and Circulating Nucleic Acids},
year = {2025},
volume = {6},
number = {4},
pages = {954--81},
doi = {10.20517/evcna.2025.107}
}
EUVIMED